Opana ER (oxymorphone hydrochloride extended-release) was a prescription opioid medication used for the management of severe, chronic pain in patients who required continuous, long-term opioid treatment. The 5 mg dosage represented the lowest strength of the extended-release formulation, often used as a starting point for opioid-tolerant patients or those being converted from other pain medications.
